In addition, the combination of the PARP inhibitor olaparib and Wee1/Chk1 inhibitor is a highly effective approach for radiosensitization of HPV-positive HNSCC cells (104). The gene discussed is CHEK1; the disease is head and neck squamous cell carcinoma.